Antony C. Mattessich, President and CEO at OCULAR THERAPEUTIX, INC (OCUL), bought 6,500 shares at $3.81 ($25K) on 2023-08-30, disclosed to the SEC on 2023-09-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| OCUL | SELL | 2023-02-08 | $167K | — | Filing → |
| OCUL | BUY | 2021-08-24 | $49K | — | Filing → |
| OCUL | BUY | 2019-06-10 | $112K | — | Filing → |